Activity of AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, in imatinib-resistant Bcr-Abl positive lymphoid malignancies.

被引：0
|
作者：
Ottmann, O
Giles, F
Wassmann, B
Hochhaus, A
Rae, P
Beran, M
Albitar, M
Alland, L
Dugan, M
Kantarjian, H
机构：
[1] Univ Frankfurt, D-6000 Frankfurt, Germany
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Heidelberg, D-6800 Mannheim, Germany
[4] Novartis Pharmaceut Corp, E Hanover, NJ USA
[5] Quest Diagnost, San Juan Capistrano, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195S / 195S
页数：1
相关论文
共 50 条
  • [41] AMN107: In vitro profile of a new inhibitor of the tyrosine kinase activity of Bcr-Abl.
    Mestan, J
    Ellen, W
    Sandra, CJ
    Doriano, F
    Pascal, F
    Gabriele, F
    Gerard, G
    Dominique, K
    Markus, G
    James, GD
    Paul, MW
    BLOOD, 2004, 104 (11) : 546A - 546A
  • [42] Activity of Serono-AS703569, a Dual Inhibitor of Bcr-Abl and Aurora Kinases in Bcr-Abl Transformed Cells, Is Dependent On Aurora B Inhibition, and Is Not Affected by the Presence of the Highly Imatinib Resistant Bcr-Abl Mutation T315I
    Seitz, Anna Katharina
    von Bubnoff, Nikolas
    Sarno, Samantha M.
    Peschel, Christian
    Duyster, Justus
    BLOOD, 2009, 114 (22) : 1258 - 1258
  • [43] In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic
    Puttini, Miriam
    Coluccia, Addolorata M. L.
    Boschelli, Frank
    Franceschino, Anna
    Tomaghi, Lucia
    Ahmed, Shaheen
    Redaelli, Sara
    Piazza, Rocco
    Magistroni, Vera
    Andreoni, Federica
    Scapozza, Leonardo
    Formelli, Franca
    Gambacorti, Carlo
    BLOOD, 2006, 108 (11) : 617A - 617A
  • [44] Bestinib, a novel Bcr-Abl inhibitor for Chronic Myeloid Leukemia, inhibits a wide array of Bcr-Abl mutants including imatinib resistant T315I mutant
    Gupta, Pranav
    Yang, Ke
    Wang, Fang
    Wang, Xiaokun
    Kathawala, Rishil J.
    Fu, Liwu
    Chen, Zhe Sheng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S100 - S100
  • [45] Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the AN kinase inhibitor nilotinib (AMN107)
    von Bubnoff, Nikolas
    Manley, Paul W.
    Mestan, Jurgen
    Sanger, Jana
    Peschel, Christian
    Duyster, Justus
    BLOOD, 2006, 108 (04) : 1328 - 1333
  • [46] Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells
    Tolomeo, Manlio
    Grimaudo, Stefania
    Di Cristina, Antonietta
    Pipitone, Rosaria M.
    Dusonchet, Luisa
    Meli, Maria
    Crosta, Lucia
    Gebbia, Nicola
    Invidiata, Francesco Paolo
    Titone, Lucina
    Simoni, Daniele
    CANCER LETTERS, 2008, 265 (02) : 289 - 297
  • [47] ASSESSMENT OF THE RESULT OF BCR-ABL MUTATION ANALYSIS IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS
    Demircioglu, S.
    Balasar, M.
    Yildirim, M.
    LEUKEMIA RESEARCH, 2016, 49 : S40 - S40
  • [48] INCREASING BCR-ABL EXPRESSION LEVELS AND/OR OCCURRENCE OF ABL POINT MUTATIONS NOT ALWAYS PREDICT RESISTANCE TO IMATINIB MESYLATE IN BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Grammatico, S.
    Elia, L.
    Vitale, A.
    Matarazzo, M.
    Falciani, V
    Rago, A.
    Cenfra, N.
    Peluso, A. L.
    Pedace, L.
    Grammatico, P.
    Pane, F.
    Meloni, G.
    Foa, R.
    Cimino, G.
    HAEMATOLOGICA, 2008, 93 : S88 - S89
  • [49] AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells
    Zhou, Liang L.
    Zhao, Yun
    Ringrose, Ashley
    DeGeer, Donna
    Kennah, Erin
    Lin, Ann E. -J.
    Sheng, Guoqing
    Li, Xiao-Jiang
    Turhan, Ali
    Jiang, Xiaoyan
    JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (11): : 2657 - 2671
  • [50] A dual Bcr-Abl/Lyn tyrosine kinase inhibitor, NS-187, is a novel agent for imatinib-resistant leukemia.
    Kimura, S
    Naito, H
    Yokota, A
    Kamitsuji, Y
    Kawata, E
    Ashihara, E
    Nakaya, Y
    Naruoka, H
    Wakayama, T
    Asaki, T
    Niwa, T
    Hirabayashi, K
    Maekawa, T
    BLOOD, 2005, 106 (11) : 437A - 438A
12345